If data from the 2 to 5 age group trials is promising, the company says it will proceed with regulatory filings to seek approval from the FDA
Wednesday it aims to report data of the efficacy of its Covid-19 vaccine in children ages 2-5 by March, and hopes to evaluate its booster shot for those ages 12-17 as Covid-related hospitalizations for children have reached record levels.... [+]
in Glasgow September 3, 2007 in Glasgow, Scotland. Medical experts still believe the MMR jab is safe and that the vaccine does not cause autism. If data from the 2 to 5 age group trials is promising, the company says it will proceed with regulatory filings to seek approval from the U.S. Food and Drug Administration.’s vaccine authorized for those ages 5 to 11.
Despite not yet having its initial two-dose vaccine approved for those ages 12 to 17, Moderna said it has been evaluating a booster dose for the age group. Pfizer’s is also the only Covid-19 vaccine approved for those ages 12 to 17 in the U.S., though Moderna’s has received authorizations in Europe, Australia and Canada.Moderna in October the agency needed more time to assess the company’s vaccine before approving it for the adolescent age group, with an update possibly coming later this month.
Moderna says it began evaluating a lower dosage for the 6-to-11 and 12-to-17 age groups in order to meet regulatory guidance.Pfizer has also been conducting trials on the efficacy of its Covid-19 vaccine for those ages 2 to 5, as well as babies ages 6 months to 2 years. In December, itinitial trials showed the vaccine was not providing the same level of immunity in those ages 2 to 5 as it does in older age groups, though it proved effective for the 6- to 24-month group.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Moderna Expects Vaccine Data For Kids Ages 2-5 By MarchIf data from the 2 to 5 age group trials is promising, the company says it will proceed with regulatory filings to seek approval from the FDA
Lire la suite »
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trialThe results of a Science study of how antibodies correlate with the degree of vaccine efficacy in people who'd received the Moderna COVID19 vaccine have helped define immune correlates of protection. Learn more ➡
Lire la suite »
COVID vaccines safely protect pregnant people: the data are inDespite evidence that pregnant people are at high risk of serious disease, many remain unvaccinated.
Lire la suite »
San Francisco updates guidance on vaccination & booster requirements for mega-eventsThe new rule changes kick in on Feb. 1 and depend on your age & vaccine eligibility status.
Lire la suite »
Army has relieved six active-duty commanders for refusing COVID-19 vaccineThe Army has not yet initiated separations for soldiers refusing the vaccine but expects further guidance later this month.
Lire la suite »
China's December exports rose 20.9% from a year ago, slightly more than expectedChina's exports grew slightly more than expected in December, while imports rose less than expected, according to customs data released on Friday.
Lire la suite »